Phase 1 Results Support Development of TopiVert Therapy for Ulcerative Colitis
News
Positive safety data from a Phase 1 trial supports TopiVert’s continued development of TOP1288 to treat ulcerative colitis, the British pharma company announced. TOP1288 targets several important enzymes including P38, Src, Lck and ... Read more